Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Emtnester isn't this the first PTO rejection of the 336?

An Office Action letter was issued last week for a nonfinal action(rejection) of claims 1-10 on this patent. this is the first non-final action on 336...it was to be expected. The patents cited as prior art, when combined, are being viewed by the examiner, as obviousness to our patent.

Share
New Message
Please login to post a reply